Coronary Artery Disease: From Medical Therapy to Intervention

CASE DISCUSSION

Coronary Artery Disease: From Medical Therapy to Intervention

Presented from by Dr Argyrios S. Ntalianis

0

Likes

9388

Views

376

Shares

0

Bookmarks

Case Description

Coronary artery disease (CAD) remains a leading cause of morbidity and mortality worldwide. Management begins with optimal medical therapy, including antiplatelets, statins, beta-blockers, ACE inhibitors, and lifestyle modification to reduce risk factors. For patients with persistent symptoms or...

Case Summary

  • Coronary artery disease (CAD) prevalence varies globally, with higher rates in North Africa, the Middle East, and Russia, while North America, Western Europe, and Australia have lower rates. In the US, nearly 20 million people have CAD, and its prevalence is influenced by age and gender. Despite a decline in CAD-related deaths, it remains a leading cause of mortality.

Speaker Profile

Dr Argyrios S. Ntalianis

Dr Argyrios S. Ntalianis

Consultant in Cardiology & Interventional Cardiology Head of the CAD and Cardiomyopathy Unit Alexandra Hospital, Athens, Greece
Dr. Argyrios S. Ntalianis is a renowned Consultant in Cardiology and Interventional Cardiology, serving as the Head of the CAD and Cardiomyopathy Unit at Alexandra Hospital in Athens, Greece. With extensive expertise in managing complex cardiac conditions, he specializes in coronary artery disease and cardiomyopathies. Dr. Ntalianis is highly regarded for his clinical skills and contributions to advancing interventional cardiology techniques. His leadership at Alexandra Hospital drives innovative patient care and research in cardiovascular medicine.

Assimilate | Coronary Artery Disease: From Medical Therapy to Intervention